Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Mushtaq, Muhammad Umair  [Clear All Filters]
2023
Shahzad M, Hussain A, Tariq E, Anwar I, Faisal MS, Syed L, Karam A, Chaudhary SGull, Ahmed N, Bansal R, et al. Outcomes of Tyrosine Kinase Inhibitors Maintenance Therapy with or without Allogeneic Hematopoietic Stem Cell Transplantation in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in First Complete Remission: A Systematic Review and Meta-Analys. Clin Lymphoma Myeloma Leuk. 2023.
Ahmed N, Wesson W, Mushtaq MUmair, Porter DL, Nasta SD, Brower J, Bachanova V, Hu M, Nastoupil LJ, Oluwole OO, et al. Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel (tisa-cel) Recipients for B Cell Non-Hodgkin Lymphoma. Transplant Cell Ther. 2023.
Din MAmmad Ud, Jaan A, Shahzad M, Liaqat H, McGuirk J, Mushtaq MUmair. Poor hospitalization outcomes in patients undergoing allogeneic hematopoietic stem cell transplant with hospital acquired influenza infection. Transpl Infect Dis. 2023:e14066.
2022
Shahzad M, Chaudhary SGull, Zafar MU, Hassan MA, Hussain A, Ali F, Anwar I, Ahmed M, Ahmed N, Khurana S, et al. Impact of COVID-19 in Hematopoietic stem cell transplant recipients: A systematic review and meta-analysis. Transpl Infect Dis. 2022.
2021
Shahzad M, Chaudhary SGull, Basit A, Thellman C, Rodriguez L, Abhyankar SH, McGuirk JP, Mushtaq MUmair. Chronic graft-versus-host disease presenting as acute polymyositis: A case series and systematic review. Transpl Immunol. 2021:101520.
Mushtaq MUmair, Shahzad M, Chaudhary SGull, Luder M, Ahmed N, Abdelhakim H, Bansal R, Balusu R, DeJarnette S, Divine C, et al. Impact of SARS-CoV-2 in hematopoietic stem cell transplant and CAR-T cell therapy recipients. Transplant Cell Ther. 2021.
Shahzad M, Siddiqui RS, Anwar I, Chaudhary SGull, Ali T, Naseem M, Ahmed TF, Ahmed Z, Khurana S, Ahmed N, et al. Outcomes with CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis. Transplant Cell Ther. 2021.